Targeting USP4 to inhibit TGF-β signaling: the antifibrotic potential of isovitexin in renal interstitial fibrosis
Phytomedicine · 2026-06 · 155 · 158141
DOI: 10.1016/j.phymed.2026.158141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026-06. Verfasst von Jianhui Fan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, China; Clinical Research Center, Affiliated Hosp…. Hauptthemen laut MEDLINE: Ubiquitin-Specific Proteases, Transforming Growth Factor beta, Kidney Diseases, Antifibrotic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Natural Science Foundation of Yunnan Province, National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
BACKGROUND: Renal interstitial fibrosis (RIF), driven by persistent TGF-β signaling, is a hallmark of progressive kidney disease. Because deubiquitinases (DUBs) like USP4 stabilize TGF-β type I receptor (TβRI) to prolong signaling, targeting USP4 represents a promising antifibrotic strategy. PURPOSE: To evaluate whether isovitexin (IVX), a plant-derived flavonoid, inhibits USP4 to destabilize TβRI, attenuate TGF-β/Smad signaling and EMT, and confer antifibrotic benefits in vitro and in vivo. METHODS: We used a unilateral ureteral obstruction (UUO) mouse model and TGF-β1-stimulated renal tubular epithelial cells (HK-2, NRK-52E). Assays included biophysical target engagement (MST, CETSA, DARTS); biochemical analyses (ubiquitination, cycloheximide-chase, proteasome activity, co-immunoprecipitation); genetic perturbations (USP4 overexpression/knockdown, mutagenesis); histology (H&E, Masson's trichrome, immunohistochemistry); and molecular techniques (Western blotting, RT-qPCR, luciferase reporter assays). RESULTS: IVX alleviated UUO-induced renal injury, reduced ECM deposition, and normalized EMT markers (E-cadherin upregulated, α-SMA/vimentin downregulated), with efficacy comparable to losartan. IVX reduced TβRI and phosphorylated Smad3 while sparing TβRII. In tubular cells, IVX increased K48-linked ubiquitination of TβRI and accelerated proteasomal degradation, thereby suppressing Smad-dependent transcription. Binding assays confirmed direct IVX-USP4 engagement (Kd = 7.59 μM), inhibition of USP4 activity, disruption of the USP4-TβRI complex, and suppression of TGF-β1-induced USP4 expression. Overexpression of catalytically active USP4 reversed the effects of IVX. CONCLUSION: IVX functions as a natural USP4 inhibitor that modulates TGF-β signaling by selectively destabilizing TβRI, supporting a DUB-centered antifibrotic strategy and positioning IVX as a promising therapeutic lead for RIF treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, China; Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, China.
- Key Laboratory of Natural Products Synthetic Biology of Ethnic Medicinal Endophytes, State Ethnic Affairs Commission, Key Laboratory of Chemistry in Ethnic Medicinal Resources, Ministry of Education, Yunnan Minzu Univer…
- Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, China; Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, China. Electro…
Förderung
- Natural Science Foundation of Yunnan Province
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Fan, J., Liu, Y., Zhan, S., Ling, H., Yan, J., Xie, L., Wang, W., Xiao, X., & Li, A. (2026). Targeting USP4 to inhibit TGF-β signaling: the antifibrotic potential of isovitexin in renal interstitial fibrosis. Phytomedicine, 155, 158141. https://doi.org/10.1016/j.phymed.2026.158141
Vancouver
Fan J, Liu Y, Zhan S, Ling H, Yan J, Xie L, et al. Targeting USP4 to inhibit TGF-β signaling: the antifibrotic potential of isovitexin in renal interstitial fibrosis. Phytomedicine. 2026;155:158141. doi:10.1016/j.phymed.2026.158141
BibTeX
@article{Fan2026,
author = {Fan, Jianhui and Liu, Yuqi and Zhan, Shihong and Ling, Huayu and Yan, Jiamin and Xie, Leyi and Wang, Weiguang and Xiao, Xiao and Li, Ao},
title = {Targeting USP4 to inhibit TGF-β signaling: the antifibrotic potential of isovitexin in renal interstitial fibrosis},
journal = {Phytomedicine},
year = {2026},
volume = {155},
pages = {158141},
doi = {10.1016/j.phymed.2026.158141}
}
EUVIMED